Resistance Testing in Drug-Naive HIV-Infected Patients: Is it Time?
Open Access
- 1 November 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (9) , 1324-1325
- https://doi.org/10.1086/496988
Abstract
Potential conflicts of interest. R.M.G. has been a paid consultant for Bayer Diagnostics, Celera Diagnostics, and ViroLogics and has received reagents and testiKeywords
This publication has 16 references indexed in Scilit:
- Should Resistance Testing Be Performed for Treatment-Naive HIV-Infected Patients? A Cost-Effectiveness AnalysisClinical Infectious Diseases, 2005
- Long-Term Persistence of Primary Genotypic Resistance After HIV-1 SeroconversionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Persistence of primary drug resistance among recently HIV-1 infected adultsAIDS, 2004
- The Epidemiology of Antiretroviral Drug Resistance among Drug‐Naive HIV‐1–Infected Persons in 10 US CitiesThe Journal of Infectious Diseases, 2004
- Progressive Reversion of Human Immunodeficiency Virus Type 1 Resistance Mutations In Vivo after Transmission of a Multiply Drug-Resistant VirusClinical Infectious Diseases, 2003
- Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA PanelClinical Infectious Diseases, 2003
- Time Trends in Primary HIV-1 Drug Resistance Among Recently Infected PersonsJAMA, 2002
- Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary InfectionJournal of Virology, 2002
- Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable ViremiaNew England Journal of Medicine, 2001
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998